L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Brenner, Thorsten ^a   Fleming, Thomas H ^a   Rosenhagen, Claudia ^a   Krauser, Ute ^a   Mieth, Markus ^a   Bruckner, Thomas ^a   Martin, Eike ^a   Nawroth, Peter P ^a   Weigand, Markus A ^b   Bierhaus, Angelika ^a   Hofer, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIOLOGICAL MARKER; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; DRUG DERIVATIVE; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE;

ACUTE LIVER FAILURE; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEASUREMENT; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; TIME; TREATMENT OUTCOME;

AGED; ARGININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; ROC CURVE; SEPSIS; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862293726     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/210454     Document Type: Article

References (55)

1. Annane D., Aegerter P., Jars-Guincestre M. C., Guidet B., Current epidemiology of septic shock: the CUB-Réa network American Journal of Respiratory and Critical Care Medicine 2003 168 2 165 172 (Pubitemid 36920969)
2. Davis J. S., Darcy C. J., Yeo T. W., Jones C., McNeil Y. R., Stephens D. P., Celermajer D. S., Anstey N. M., Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis PLoS ONE 2011 6 2
3. Gough M. S., Morgan M. A.M., MacK C. M., Darling D. C., Frasier L. M., Doolin K. P., Apostolakos M. J., Stewart J. C., Graves B. T., Arning E., Bottiglieri T., Mooney R. A., Frampton M. W., Pietropaoli A. P., The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis Critical Care Medicine 2011 39 6 1351 1358
4. O'Dwyer M. J., Dempsey F., Crowley V., Kelleher D. P., McManus R., Ryan T., Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study Critical Care 2006 10 5, article R139
5. Cooke J. P., Asymmetrical Dimethylarginine: the ber Marker? Circulation 2004 109 15 1813 1819
6. Forstermann U., Schmidt H. H. H. W., Pollock J. S., Sheng H., Mitchell J. A., Warner T. D., Nakane M., Murad F., Isoforms of nitric oxide synthase. Characterization and purification from different cell types Biochemical Pharmacology 1991 42 10 1849 1857
7. Askanazi J., Carpentier Y. A., Michelsen C. B., Muscle and plasma amino acids following injury. Influence of intercurrent infection Annals of Surgery 1980 192 1 78 85 (Pubitemid 10083265)
8. Barbul A., Uliyargoli A., Use of exogenous arginine in multiple organ dysfunction syndrome and sepsis Critical Care Medicine 2007 35 9 S564 S567
9. Chiarla C., Giovannini I., Siegel J. H., Plasma arginine correlations in trauma and sepsis Amino Acids 2006 30 1 81 86 (Pubitemid 43261130)
10. Freund H., Atamian S., Holroyde J., Fischer J. E., Plasma amino acids as predictors of the severity and outcome of sepsis Annals of Surgery 1979 190 5 571 576 (Pubitemid 10213662)
11. Kalil A. C., Danner R. L., L-Arginine supplementation in sepsis: beneficial or harmful? Current Opinion in Critical Care 2006 12 4 303 308 (Pubitemid 44078141)
12. Luiking Y. C., Poeze M., Dejong C. H., Ramsay G., Deutz N. E., Sepsis: an arginine deficiency state? Critical Care Medicine 2004 32 10 2135 2145 (Pubitemid 39372550)
13. Milewski P. J., Threlfall C. J., Heath D. F., Intracellular free amino acids in undernourished patients with or without sepsis Clinical Science 1982 62 1 83 91 (Pubitemid 12191543)
14. Ochoa J. B., Makarenkova V., Bansal V., A rational use of immune enhancing diets: when should we use dietary arginine supplementation? Nutrition in Clinical Practice 2004 19 3 216 225 (Pubitemid 38747819)
15. Ochoa J. B., Udekwu A. O., Billiar T. R., Curran R. D., Cerra F. B., Simmons R. L., Peitzman A. B., Nitrogen oxide levels in patients after trauma and during sepsis Annals of Surgery 1991 214 5 621 626
16. Popovic P. J., Zeh H. J. III, Ochoa J. B., Arginine and immunity Journal of Nutrition 2007 137 6
17. Weitzel L. R. B., Mayles W. J., Sandoval P. A., Wischmeyer P. E., Effects of pharmaconutrients on cellular dysfunction and the microcirculation in critical illness Current Opinion in Anaesthesiology 2009 22 2 177 183
18. Wu G., Morris S. M. Jr., Arginine metabolism: nitric oxide and beyond Biochemical Journal 1998 336 1 1 17 (Pubitemid 28532555)
19. Nijveldt R. J., Teerlink T., van der Hoven B., Siroen M. P. C., Kuik D. J., Rauwerda J. A., van Leeuwen P. A. M., Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality Clinical Nutrition 2003 22 1 23 30 (Pubitemid 36193177)
20. Siroen M. P. C., van Leeuwen P. A. M., Nijveldt R. J., Teerlink T., Wouters P. J., van den Berghe G., Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Critical Care Medicine 2005 33 3 504 510 (Pubitemid 40365549)
21. Bger R. H., Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor Journal of Nutrition 2004 134 10, supplement 2842S 2847S. discussion 2853S
22. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J. L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Critical Care Medicine 2003 31 4 1250 1256 (Pubitemid 36444440)
23. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M., Early goal-directed therapy in the treatment of severe sepsis and septic shock The New England Journal of Medicine 2001 345 19 1368 1377
24. Russell J. A., Management of sepsis The New England Journal of Medicine 2006 355 16 1699 1713 (Pubitemid 44583960)
25. Weigand M. A., Bardenheuer H. J., Bttiger B. W., Clinical management of patients with sepsis Anaesthesist 2003 52 1 3 22 (Pubitemid 36228435)
26. Miyaoka K., Iwase M., Suzuki R., Kondo G., Watanabe H., Ito D., Nagumo M., Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation Journal of Surgical Research 2005 125 2 144 150 (Pubitemid 40602385)
27. Davis J. S., Anstey N. M., Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis Critical Care Medicine 2010 39 2 380 385
28. Davis J. S., Yeo T. W., Thomas J. H., McMillan M., Darcy C. J., McNeil Y. R., Cheng A. C., Celermajer D. S., Stephens D. P., Anstey N. M., Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study Critical Care 2009 13 5 R155
29. De Gennaro Colonna V., Bonomo S., Ferrario P., Bianchi M., Berti M., Guazzi M., Manfredi B., Muller E. E., Berti F., Rossoni G., Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats European Journal of Pharmacology 2007 557 2-3 178 185 (Pubitemid 46186290)
30. Vallance P., Leone A., Calver A., Collier J., Moncada S., Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure The Lancet 1992 339 8793 572 575
31. Closs E. I., Basha F. Z., Habermeier A., Frstermann U., Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B Nitric Oxide 1997 1 1 65 73 (Pubitemid 28078129)
32. Abbasi F., Asagmi T., Cooke J. P., Lamendola C., McLaughlin T., Reaven G. M., Stuehlinger M., Tsao P. S., Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus American Journal of Cardiology 2001 88 10 1201 1203 (Pubitemid 33043860)
33. Bger R. H., Bode-Bger S. M., Szuba A., Tsao P. S., Chan J. R., Tangphao O., Blaschke T. F., Cooke J. P., Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia Circulation 1998 98 18 1842 1847 (Pubitemid 28509278)
34. Dayal S., Lentz S. R., ADMA and hyperhomocysteinemia Vascular Medicine 2005 10 1 S27 S33
35. Kielstein J. T., Bger R. H., Bode-Bger S. M., Frlich J. C., Haller H., Ritz E., Fliser D., Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease Journal of the American Society of Nephrology 2002 13 1 170 176 (Pubitemid 34042024)
36. Mittermayer F., Krzyzanowska K., Exner M., Mlekusch W., Amighi J., Sabeti S., Minar E., Mller M., Wolzt M., Schillinger M., Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 11 2536 2540 (Pubitemid 44607477)
37. Surdacki A., Nowicki M., Sandmann J., Tsikas D., Boeger R. H., Bode-Boeger S. M., Kruszelnicka-Kwiatkowska O., Kokot F., Dubiel J. S., Froelich J. C., Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension Journal of Cardiovascular Pharmacology 1999 33 4 652 658 (Pubitemid 29164831)
38. Iapichino G., Umbrello M., Albicini M., Spanu P., Bellani G., Polli F., Pavlovic R., Cugno M., Fermo I., Paroni R., Time course of endogenous nitric oxide inhibitors in severe sepsis in humans Minerva Anestesiologica 2010 76 5 325 333
39. Nakamura T., Sato E., Fujiwara N., Kawagoe Y., Suzuki T., Ueda Y., Yamada S., Shoji H., Takeuchi M., Ueda S., Matsui T., Adachi H., Okuda S., Yamagishi S. I., Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock Pharmacological Research 2009 60 6 515 518
40. Zoccali C., Maas R., Cutrupi S., Pizzini P., Finocchiaro P., Cambareri F., Panuccio V., Martorano C., Schulze F., Enia G., Tripepi G., Boger R., Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections Nephrology Dialysis Transplantation 2007 22 3 801 806 (Pubitemid 46351688)
41. Tsikas D., Bger R. H., Sandmann J., Bode-Bger S. M., Frlich J. C., Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox FEBS Letters 2000 478 1-2 1 3 (Pubitemid 30462247)
42. Nijveldt R. J., Teerlink T., Siroen M. P. C., van Lambalgen A. A., Rauwerda J. A., van Leeuwen P. A. M., The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA) Clinical Nutrition 2003 22 1 17 22 (Pubitemid 36193176)
43. Kimoto M., Tsuji H., Ogawa T., Sasaoka K., Detection of N(G),N(G)-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody Archives of Biochemistry and Biophysics 1993 300 2 657 662 (Pubitemid 23232925)
44. Ogawa T., Kimoto M., Sasaoka K., Purification and properties of a new enzyme, N(G),N(G)-dimethylarginine dimethylaminohydrolase, from rat kidney Journal of Biological Chemistry 1989 264 17 10205 10209 (Pubitemid 19159295)
45. Teerlink T., ADMA metabolism and clearance Vascular Medicine 2005 10 1 S73 S81
46. Eiselt J., Rajdl D., Racek J., irok R., Trefil L., Opatrn S., Asymmetric dimethylarginine in hemodialysis, hemodiafiltration, and peritoneal dialysis Artificial Organs 2010 34 5 420 425
47. Lluch P., Torondel B., Medina P., Segarra G., Del Olmo J. A., Serra M. A., Rodrigo J. M., Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis Journal of Hepatology 2004 41 1 55 59 (Pubitemid 39005153)
48. Mookerjee R. P., Dalton R. N., Davies N. A., Hodges S. J., Turner C., Williams R., Jalan R., Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure Liver Transplantation 2007 13 3 400 405 (Pubitemid 46444469)
49. Bernard A., Kasten M., Meier C., Manning E., Freeman S., Adams W., Chang P., Boulanger B., Kearney P., Red blood cell arginase suppresses Jurkat (T cell) proliferation by depleting arginine Surgery 2008 143 2 286 291
50. Bernard A., Meier C., Lopez N., May J., Chang P., Boulanger B., Kearney P., Packed red blood cell-associated arginine depletion is mediated by arginase Journal of Trauma 2007 63 5 1108 1112. discussion 1112 (Pubitemid 350098535)
51. Kim P. S., Iyer R. K., Lu K. V., Yu H., Karimi A., Kern R. M., Tai D. K., Cederbaum S. D., Grody W. W., Expression of the liver form of arginase in erythrocytes Molecular Genetics and Metabolism 2002 76 2 100 110 (Pubitemid 34757133)
52. Rotoli B. M., Closs E. I., Barilli A., Visigalli R., Simon A., Habermeier A., Bianchi N., Gambari R., Gazzola G. C., Bussolati O., Dall'Asta V., Arginine transport in human erythroid cells: discrimination of CAT1 and 4F2hc/y+LAT2 roles Pflugers Archiv European Journal of Physiology 2009 458 6 1163 1173
53. Bger R. H., Bode-Bger S. M., Thiele W., Junker W., Alexander K., Frlich J. C., Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease Circulation 1997 95 8 2068 2074 (Pubitemid 27184275)
54. Selley M. L., Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease Neurobiology of Aging 2003 24 7 903 907 (Pubitemid 36962974)
55. Kielstein J. T., Bger R. H., Bode-Bger S. M., Schffer J., Barbey M., Koch K. M., Frlich J. C., Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease Journal of the American Society of Nephrology 1999 10 3 594 600 (Pubitemid 29117641)